The Influence of Modifying Highly Calcified Coronary Lesions on Coronary Microcirculation

NCT06507449 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-11-24

No results posted yet for this study

Summary

This is a prospective, single-center, three-arm study to evaluate the impact of severely calcified coronary lesions treatment on microvascular circulation. We will enroll 30 conveniently sampled subjects assigned to one of three therapeutical methods lithotripsy, super-high pressure balloon, and orbital atherectomy prior to implantation of drug-eluting stents (DES).

Conditions

  • Coronary Artery Calcification
  • Ischemic Heart Disease
  • Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
  • Coronary Artery Disease
  • Angina, Unstable
  • Tomography, Optical Coherence

Interventions

DEVICE

Lithotripsy

Calcified lesion preparation using lithotripsy before implantation of a drug-eluting stent

DEVICE

Orbital atherectomy

Calcified lesion preparation using orbital atherectomy before implantation of a drug-eluting stent

DEVICE

High-pressure non-compliant balloon

Calcified lesion preparation using high-pressure non-compliant balloon before implantation of a drug-eluting stent

DEVICE

Optical coherence tomography

Optical coherence tomography assessment of coronary arteries.

DEVICE

Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire

A coronary thermodilution system used for evaluate differences between the impact of calcified lesion preparation methods on coronary microvascular function.

Sponsors & Collaborators

  • Polish Cardiac Society

    collaborator OTHER
  • Medical University of Silesia

    lead OTHER

Principal Investigators

  • Paweł Gąsior, MD, PhD · Division of Cardiology and Structural Heart Diseases, Medical University of Silesia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-07
Primary Completion
2026-06-30
Completion
2026-12-31
FDA Device
Yes

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06507449 on ClinicalTrials.gov